Zobrazeno 1 - 10
of 35
pro vyhledávání: '"SOICHI FUMITA"'
Autor:
Akihiro Tokoro, Hisao Imai, Soichi Fumita, Toshiyuki Harada, Toshio Noriyuki, Makio Gamoh, Yusaku Akashi, Hiroki Sato, Yoshiyuki Kizawa
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4883-4891 (2019)
Abstract This multicenter, prospective, observational cohort study assessed opioid induced constipation (OIC) in Japanese patients with cancer. Eligible patients had stable cancer and an ECOG PS of 0‐2. OIC incidence based on the Rome IV diagnostic
Externí odkaz:
https://doaj.org/article/9702a80e977944509a38660a85d82b1d
Autor:
Hironobu Minami, Kazuhiko Nakagawa, Soichi Fumita, Tomoo Ito, Shigeo Hara, Yutaka Okita, Kenji Okada, Takanori Oka, Tomonori Shirasaka, Naomi Kiyota, Yutaka Fujiwara, Naoko Chayahara, Hideo Tomioka, Tomoko Kataoka, Toru Mukohara, Yohei Funakoshi
Publikováno v:
Rare Tumors, Vol 2, Iss 3, Pp e53-e53 (2010)
Extension of metastatic lung tumors into the left atrium via pulmonary veins is rare. Here, we report the first case of Ewing sarcoma exhibiting such extension. A 31-year-old man with pulmonary metastasis from Ewing sarcoma presented with a mass in t
Externí odkaz:
https://doaj.org/article/8ad6cad91f9b4796ab694b4cf0cd2041
Autor:
Daisuke Sakai, Takeshi Omori, Soichi Fumita, Junya Fujita, Ryohei Kawabata, Jin Matsuyama, Hisateru Yasui, Motohiro Hirao, Tomono Kawase, Kentaro Kishi, Yoshiki Taniguchi, Yasuhiro Miyazaki, Junji Kawada, Hironaga Satake, Tomoko Miura, Akimitsu Miyake, Yukinori Kurokawa, Makoto Yamasaki, Tomomi Yamada, Taroh Satoh, Hidetoshi Eguchi, Yuichiro Doki
Publikováno v:
International Journal of Clinical Oncology. 27:1154-1163
Background Real-world evidence on the preference for and effectiveness of third- or later-line (3L +) monotherapy for HER2-positive gastric cancer is limited in Japan. This study evaluated the utility of nivolumab, irinotecan, and trifluridine/tipira
Autor:
Shinichiro Suzuki, Kazuya Fukuoka, Hisato Kawakami, Soichi Fumita, Kazuhiko Nakagawa, Hidetoshi Hayashi, Chihiro Sato, Kazuko Sakai, Shigeki Shimizu, Tatsuya Okuno, Koji Haratani, Akihiko Ito, Yoshikane Nonagase, Kazumasa Saigoh, Kimio Yonesaka, Hisashi Handa, Takeshi Yoshida, Masayuki Takeda, Tetsuya Mitsudomi, Kazuto Nishio, Takayuki Takahama, Naoki Takegawa, Satomi Watanabe, Kaoru Tanaka
Publikováno v:
The Oncologist
Background Implementation of personalized medicine requires the accessibility of tumor molecular profiling in order to allow prioritization of appropriate targeted therapies for individual patients. Our aim was to study the role of comprehensive geno
Autor:
Hisao Imai, Masaharu Okamoto, Soichi Fumita, Yoshiyuki Kizawa, Toshio Noriyuki, Makio Gamoh, Toshiyuki Harada, Yusaku Akashi, Akihiro Tokoro
Publikováno v:
Japanese Journal of Clinical Oncology
Objective To evaluate the opioid-induced constipation burden in the subgroup of patients with lung cancer who participated in the observational Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J) study. Methods The prospective,
Autor:
Hisao Imai, Makio Gamoh, Akihiro Tokoro, Toshio Noriyuki, Masaharu Okamoto, Soichi Fumita, Yoshiyuki Kizawa, Toshiyuki Harada, Yusaku Akashi
Publikováno v:
International Journal of Clinical Oncology
Background Constipation is a common side effect of opioid therapy. An observational study of opioid-induced constipation (OIC) in Japanese patients with cancer (OIC-J) included 212 patients with various tumor types. This post hoc analysis of OIC-J ev
Autor:
Kazuhiko Nakagawa, Seiichiro Mitani, Shinichiro Suzuki, Takashi Kurosaki, Yasumasa Nishimura, Hidetoshi Hayashi, Soichi Fumita, Naoki Otsuki, Kazuki Ishikawa, Takeshi Yoshida, Katsumi Doi, Hiroaki Kanemura, Koji Haratani, Kaoru Tanaka, Mutsukazu Kitano, Tsutomu Iwasa
Publikováno v:
Anti-Cancer Drugs
Immunotherapy has been shown to prolong survival in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) in front-line use; however, subsequent systemic therapy has not been optimized. This study aimed to evaluate the safety a
Autor:
Shuichi Fukuda, Tomoko Wakasa, Hironobu Manabe, Takao Tamura, Kotaro Kitani, Hajime Ishikawa, Yoshio Ohta, Keisuke Inoue, Soichi Fumita, Shigeto Mizuno, Shinya Ueda, Noriko Ichimura, Toshihiko Kawasaki, Masao Yukawa, Kaoru Okada, Masanori Tsujie, Masatoshi Inoue, Shumpei Satoi
Publikováno v:
International Journal of Surgery Case Reports
Highlights • The patient was diagnosed with PDAC with distant lymph node metastases (para-aortic lymph nodes and Virchow’s lymph node). • After systemic chemotherapy using FOLFIRINOX, conversion surgery (pancreaticoduodenectomy) was performed.
Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J Study): A Post Hoc Analysis
Autor:
Toshiyuki Harada, Yusaku Akashi, Hisao Imai, Masaharu Okamoto, Yoshiyuki Kizawa, Toshio Noriyuki, Makio Gamoh, Soichi Fumita, Akihiro Tokoro
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 18
Journal of Clinical Medicine, Vol 10, Iss 4193, p 4193 (2021)
Volume 10
Issue 18
Journal of Clinical Medicine, Vol 10, Iss 4193, p 4193 (2021)
Opioid-induced constipation (OIC) can limit the clinical benefit of opioid treatment. This post-hoc analysis evaluated the association between the Rome IV diagnostic criteria and other measures for OIC, including the Bowel Function Index (BFI), corre
Autor:
Y-K. Kang, L.-T. Chen, Hiroki Hara, Yoshito Komatsu, Masahiro Tsuda, Ken Kato, Hyun Cheol Chung, Mizutomo Azuma, Narikazu Boku, H. Cho, Kensei Yamaguchi, Soichi Fumita, Won Ki Kang, Keun Wook Lee, Min-Hee Ryu, Keiko Minashi
Publikováno v:
Annals of Oncology
Background Nivolumab is approved as an option for third- or later-line treatment of advanced gastric/gastroesophageal junction (G/GEJ) cancer in several countries after ATTRACTION-2. To further improve the therapeutic efficacy of first-line therapy,